Gilead to buy cancer candidate from Repare Thera (RPTX:NASDAQ)

Repair therapeutics (RPTX) added ~20% in pre-market trading on Wednesday after the company announced an asset purchase agreement to sell its experimental cancer treatment RP-3467 to Gilead (BROWN) in a deal worth up to $30 million.

According to the terms, the Canadian